Abstract
Dermatitis herpetiformis (DH) is a rare disease characterized by a chronic, papulove-sicular eruption; it is intensely pruritic and associated with immunoglobulin A (IgA) deposition in the papillary dermis. It is accompanied by an underlying gluten-sensitive enteropathy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further reading
Dietrich W, Laag E, Bruckner-Tuderman L et al Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 1999; 113 (1): 133–6.
Fry L. Dermatitis herpetiformis. In: Wojnarowska F, Briggaman R, eds. Management of Blistering Disease. London: Chapman & Hall Medical, 1990: 139–62.
Hardman CM, Garioch JJ, Leonard JN et al Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 1997; 337 (26): 1884–7.
Lewis H, Reunala T, Garioch J etal. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 1996; 135: 363–7.
McFadden J, Leonard J, Powles A et al Sulphamethoxypyridazine for dermatitis, herpetiformis, linear IgA disease and cicatrical pemphigoid. Br J Dermatol 1989; 121: 759–62.
Rhodes L, Tingle M, Park B etal. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy. Br J Dermatol 1959; 132: 25 7–62.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gooptu, C., Wojnarowska, F. (2003). Dermatitis herpetiformis. In: Katsambas, A.D., Lotti, T.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07131-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-662-07131-1_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-05657-4
Online ISBN: 978-3-662-07131-1
eBook Packages: Springer Book Archive